Nanobiotix S.A. American Depositary Shares (NBTX)
Company News
Nanobiotix announced the presentation of full results from a Phase 1 study evaluating JNJ-1900 (NBTXR3) in patients with locally advanced or borderline resectable pancreatic cancer. The study will be presented at the ESTRO 2025 conference, and Nanobiotix will host a conference call to discuss the data.
U.S. stock futures were lower this morning, with the Dow futures falling over 150 points on Thursday. Shares of CarMax, Inc. (NYSE: KMX) fell sharply in today’s pre-market trading after the company reported lower-than-expected fourth-quarter earnings. CarMax posted quarterly earnings of 32 cents per share, missing market estimates of 49 cents per share. The company’s quarterly sales came in at $5.63 billion versus expectations of $5.79 billion, according to data from Benzinga Pro. CarMax shares dipped 9.1% to $72.06 in pre-market trading. Here are some big stocks recording losses in today’s pre-market ...